Discover the latest articles and industry news about health system specialty pharmacy, Excelera and the Excelera Network.
Specialty Pharmacies Must be Value-Driven, Patient-Centric to Remain Competitive
The high number of specialty drugs emerging into the marketplace has increased competition among independent pharmacies and chain pharmacies. As the health care industry moves towards value-based reimbursement, health plans, pharmacy benefit managers (PBMs), physicians, and hospitals are looking to partner with pharmacies that have proven the ability to deliver high-value care at a low cost, according a new white paper from URAC.
Provider-owned specialty pharmacies are fastest-growing segment
The majority of specialty pharmacies are independently owned, but those owned by health care providers such as hospitals and health plans constitute the fastest-growing segment, according to the Drug Channels Institute. In 2016, about 2,500 specialty pharmacy locations dispensed approximately $115 billion in medications.
Patient Satisfaction – The True Differentiator for Specialty Pharmacies
The rapid proliferation of specialty pharmacies has led to a growing need to create models that truly differentiate the various offerings in the marketplace. Specialty medications now account for more than one-third of all spending on drugs in the United States.
Health Systems Disrupt the Specialty Pharmacy Market to Improve Patient Care
The authors argue that specialty pharmacy programs at health systems provide significant advantages to hospitals, health systems, and patients. They highlight the specific benefits for organ transplant and hepatitis C patients.
In-house specialty pharmacy reduces medical errors, wait time
The addition of an in-house specialty pharmacy at a cancer center in Connecticut reduced the amount of time patients waited for oral cancer medications; prevented errors associated with filling, dispensing and taking oral chemotherapy; and improved overall quality of care, according to a study being presented at the Quality Care Symposium.
Fairview asks: Can genetic tests improve high blood pressure care? Fairview asks: Can genetic tests improve high blood pressure care?
Fairview Health Services is collaborating with a local genetics research firm to determine if DNA tests can steer patients to more effective treatment for high blood pressure, a condition that afflicts more than 1 million Minnesotans.
There are nearly 7,000 rare diseases characterized by a wide variety of symptoms, and managing these conditions presents unique challenges, speakers said at the Academy of Managed Care Pharmacy’s 2016 annual meeting.
Minding the Gap: Why Access to Electronic Medical Records Matters in Specialty Pharmacy
In the data- and outcomes-driven paradigm that is shaping health care today, access to the electronic medical record (EMR) is a key factor that distinguishes health-system specialty pharmacies from their non-integrated competitors.
The Sleeping Giant: Health Systems Awaken to the Opportunities and Risks of Entering the Specialty Pharmacy Arena
As health care payment models shift toward risk-sharing, pay-for-performance, and accountable care organizations (ACO), hospitals and health systems are waking up to the realization that decisions they make regarding specialty pharmacy could affect clinical outcomes, color the patient experience, and impact the bottom line for years to come.
The Movement Towards Hospital-Owned Specialty Pharmacies [White Paper]
Provider-owned specialty pharmacies are one of pharmaceuticals’ hottest trends. Learn why—and how this shift will impact your relationships with provider customers.Why are providers investing in their own specialty pharmacies? What traits make a provider more likely to make this investment? This white paper explores the answers to those questions, as well as what the marketplace might look like in the future and how this trend will impact suppliers and service providers.